In Australia, approximately 75% of children with allergies will experience persistent allergies, including anaphylaxis, into adulthood. Anaphylaxis is the most severe form of allergic reaction. It develops rapidly in response to allergen exposure and can be life-threatening or, in some cases, fatal. Living with the risk of anaphylaxis is often associated with a high emotional burden,…

Read More

Today (Friday, 1 October, 2021), adults living with severe corneal inflammation from dry eye disease (DED) that has not improved with the use of artificial tears, will gain affordable access to a new, once-daily treatment option on the Pharmaceutical Benefits Scheme (PBS). In-licensed for the first time in Australia by Seqirus – a wholly-owned subsidiary…

Read More

Q: Tell us a bit about your background and what do you bring to the VIVA! team. A: I’m currently finishing up my Bachelor of Media and Communications at Macquarie University. This is my first role in healthcare PR. Before this I was a nanny and worked in retail so, I very excited at the…

Read More